{"id":178,"date":"2024-08-21T00:52:59","date_gmt":"2024-08-21T00:52:59","guid":{"rendered":"https:\/\/naujienosversle.lt\/index.php\/2024\/08\/21\/berlyne-isikurusi-reliant-ai-slapta-paleidziama-101-mln-eur-skirta-dirbtinio-intelekto-analizei-biofarma\/"},"modified":"2024-08-21T00:52:59","modified_gmt":"2024-08-21T00:52:59","slug":"berlyne-isikurusi-reliant-ai-slapta-paleidziama-101-mln-eur-skirta-dirbtinio-intelekto-analizei-biofarma","status":"publish","type":"post","link":"https:\/\/naujienosversle.lt\/index.php\/2024\/08\/21\/berlyne-isikurusi-reliant-ai-slapta-paleidziama-101-mln-eur-skirta-dirbtinio-intelekto-analizei-biofarma\/","title":{"rendered":"Berlyne \u012fsik\u016brusi \u201eReliant AI\u201c slapta paleid\u017eiama 10,1 mln. EUR, skirta dirbtinio intelekto analizei biofarma"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div>\n<p><a href=\"https:\/\/www.reliant.ai\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Patikimas AI<\/span><\/a><span style=\"font-weight: 400;\">\u201eGen AI\u201c pagr\u012fstos duomen\u0173 analiz\u0117s programin\u0117s \u012frangos tiek\u0117jas paskelb\u0117 apie savo slapt\u0105 paleidim\u0105 ir pradin\u012f finansavim\u0105 10,1 mln. Naujajai sostinei vadovavo \u201eTola Capital\u201c ir \u201eInovia Capital\u201c, dalyvaujant angelui investuotojui Mike&#8217;ui Volpi.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Reliant AI suk\u016br\u0117 pirmaujantys nat\u016bralios kalbos apdorojimo ir mokymosi stiprinimo mokslininkai ir tyrin\u0117tojai Karlas Moritzas Hermannas, Marcas Bellemare&#8217;as ir Richardas Schlegelis, kurie vadovavo DeepMind, Google Brain ir EY Parthenon komandoms. Jie aistringai vertina tai, kaip generatyvus AI gali i\u0161spr\u0119sti informacijos i\u0161\u0161\u016bkius, kad b\u016bt\u0173 suma\u017eintas pasikartojantis protinis darbas ir paspartintas \u012fmoni\u0173 sprendim\u0173 pri\u0117mimas. Bendrov\u0117 i\u0161 prad\u017ei\u0173 orientuojasi \u012f biofarmacijos pramon\u0119 ir panaudos nauj\u0105 finansavim\u0105 in\u017einieriaus talent\u0173 samdymui, kad padidint\u0173 investicijas \u012f technologijas ir veiklos apimt\u012f Europoje ir \u0160iaur\u0117s Amerikoje.<\/span><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Turinys;<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/naujienosversle.lt\/index.php\/2024\/08\/21\/berlyne-isikurusi-reliant-ai-slapta-paleidziama-101-mln-eur-skirta-dirbtinio-intelekto-analizei-biofarma\/#AI_produktas_gyvybes_mokslui\" >AI produktas gyvyb\u0117s mokslui<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/naujienosversle.lt\/index.php\/2024\/08\/21\/berlyne-isikurusi-reliant-ai-slapta-paleidziama-101-mln-eur-skirta-dirbtinio-intelekto-analizei-biofarma\/#Galimybe_biofarmoje\" >Galimyb\u0117 biofarmoje<\/a><\/li><\/ul><\/nav><\/div>\n<h3><span class=\"ez-toc-section\" id=\"AI_produktas_gyvybes_mokslui\"><\/span><b>AI produktas gyvyb\u0117s mokslui<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><i><span style=\"font-weight: 400;\">\u201eInformacija ir duomenys yra kriti\u0161kai nepasteb\u0117ta dalis, siekiant gyvyb\u0117s moksl\u0173 pa\u017eangos siekiant geresnio pasaulio. Did\u017eiulis niekingas darbas \u0161iandien daug duomen\u0173 reikalaujan\u010diose pramon\u0117s \u0161akose rei\u0161kia, kad daugelis auk\u0161tos kvalifikacijos specialist\u0173 yra sutelk\u0119 d\u0117mes\u012f \u012f duomen\u0173 keitim\u0105, o ne \u012f sud\u0117ting\u0173 problem\u0173 sprendim\u0105. Suk\u016br\u0117me dirbtinio intelekto sistem\u0105, kuri supranta gyvyb\u0117s mokslus, kad i\u0161 esm\u0117s padidint\u0173 savo galimybes atlikti mokslinius tyrimus pla\u010diu mastu.<\/span><\/i><span style=\"font-weight: 400;\">  sak\u0117 Karlas Moritzas Hermannas, \u201eReliant AI\u201c generalinis direktorius ir vienas i\u0161 \u012fk\u016br\u0117j\u0173.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Pirmasis \u201eReliant AI\u201c produktas \u201eReliant Tabular\u201c yra AI darbo stalas, kuris sulaukia didelio susidom\u0117jimo pagrindiniuose biofarmacijos pramon\u0117s verslo segmentuose. \u0160is produktas padeda gyvosios gamtos moksl\u0173 analitikams rasti mokslini\u0173 \u012frodym\u0173, patvirtinan\u010di\u0173 savo sprendimus, naudojant automatines sistemines per\u017ei\u016bras, turto nuskaitymus, i\u0161samias analizes ir pritaikom\u0105 duomen\u0173 platform\u0105 \u2013 naudojant \u201eReliant AI\u201c galima u\u017eduoti bet k\u0105.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201eReliant Tabular\u201c funkcijos apima patentuotus ML modelius, optimizuotus b\u016bti biofarmacijos tem\u0173 ekspertais, visapusi\u0161k\u0105 po\u017ei\u016br\u012f \u012f fakt\u0173 nustatym\u0105 \u2013 maksimal\u0173 prisiminim\u0105, kad nieko neprarastum\u0117te, <\/span><span style=\"font-weight: 400;\">vartotojo s\u0105saja, leid\u017eianti greitai ir lengvai suderinti sugeneruotus rezultatus su pagrindine tiesa ir atsakymais ataskaitoms paruo\u0161tu formatu, kad komandos gal\u0117t\u0173 bendradarbiauti atlikdamos analiz\u0119.<\/span><\/p>\n<h3><span class=\"ez-toc-section\" id=\"Galimybe_biofarmoje\"><\/span><b>Galimyb\u0117 biofarmoje<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><i><span style=\"font-weight: 400;\">\u201eBiologin\u0117s farmacijos pramon\u0117 turi did\u017eiul\u012f ir nepakankamai aptarnaujamos informacijos poreik\u012f. Patikimas AI sujungia pa\u017eangiausius tyrimus su srities \u017einiomis, kad sukurt\u0173 programin\u0119 \u012frang\u0105, leid\u017eian\u010di\u0105 per 30 sekund\u017ei\u0173 atlikti vis\u0105 dien\u0105 reikaling\u0105 duomen\u0173 gin\u010d\u0105. Marcas, Karlas Moritzas ir j\u0173 technin\u0117 komanda sujungia de\u0161imtme\u010di\u0173 AI patirt\u012f i\u0161 geriausi\u0173 pasaulio tyrim\u0173 grupi\u0173, toki\u0173 kaip \u201eDeepMind\u201c, \u201eGoogle Brain\u201c ir \u201eMeta\u201c, suteikdami \u201eReliant\u201c galimyb\u0119 i\u0161 tikr\u0173j\u0173 nukreipti generatyvinio AI pritaikym\u0105 sprend\u017eiant sud\u0117ting\u0173 duomen\u0173 problemas. \u201c<\/span><\/i><span style=\"font-weight: 400;\">  komentavo Aaronas Fleishmanas, \u201eTola Capital\u201c partneris.<\/span><\/p>\n<p><i><span style=\"font-weight: 400;\">\u201eMes matome didel\u0119 rinkos galimyb\u0119 farmacijos sektoriuje, nes \u012fmon\u0117s stengiasi kurti ir bendradarbiauti su naujais rinkos dalyviais, kad sukurt\u0173 novatori\u0161kus sprendimus, tokius kaip si\u016blo Reliant AI\u201c,<\/span><\/i><span style=\"font-weight: 400;\">  prid\u016br\u0117 Steve&#8217;as Woodsas, \u201eInovia Capital\u201c partneris.<\/span><i><span style=\"font-weight: 400;\">  \u201e\u0160i didel\u0117 paklausa didel\u0117je ir augan\u010dioje rinkoje pabr\u0117\u017eia AI potencial\u0105 paskatinti didel\u0119 pa\u017eang\u0105 biofarmacijos pramon\u0117je.<\/span><\/i><\/p>\n<\/div>\n<p><script>\n        !function(f,b,e,v,n,t,s)\n        {if(f.fbq)return;n=f.fbq=function(){n.callMethod?\n            n.callMethod.apply(n,arguments):n.queue.push(arguments)};\n            if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version='2.0';\n            n.queue=();t=b.createElement(e);t.async=!0;\n            t.src=v;s=b.getElementsByTagName(e)(0);\n            s.parentNode.insertBefore(t,s)}(window, document,'script',\n            'https:\/\/connect.facebook.net\/en_US\/fbevents.js');\n        fbq('init', '154586475232058');\n        fbq('track', 'PageView');\n    <\/script><br \/>\n<br \/><br \/>\n<br \/><a href=\"https:\/\/www.eu-startups.com\/2024\/08\/berlin-based-reliant-ai-launches-out-of-stealth-with-e10-1-million-to-bring-ai-analytics-to-biopharma\/\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Patikimas AI\u201eGen AI\u201c pagr\u012fstos duomen\u0173 analiz\u0117s programin\u0117s \u012frangos tiek\u0117jas paskelb\u0117 apie savo slapt\u0105 paleidim\u0105 ir pradin\u012f finansavim\u0105 10,1 mln. Naujajai sostinei vadovavo \u201eTola Capital\u201c ir \u201eInovia Capital\u201c, dalyvaujant angelui investuotojui Mike&#8217;ui Volpi. Reliant AI suk\u016br\u0117 pirmaujantys nat\u016bralios kalbos apdorojimo ir mokymosi stiprinimo mokslininkai ir tyrin\u0117tojai Karlas Moritzas Hermannas, Marcas Bellemare&#8217;as ir Richardas Schlegelis, kurie vadovavo&#8230;<\/p>\n","protected":false},"author":1,"featured_media":179,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[6],"tags":[],"class_list":["post-178","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-europos-verslo-naujienos"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/posts\/178","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/comments?post=178"}],"version-history":[{"count":0,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/posts\/178\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/media\/179"}],"wp:attachment":[{"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/media?parent=178"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/categories?post=178"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/naujienosversle.lt\/index.php\/wp-json\/wp\/v2\/tags?post=178"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}